210 related articles for article (PubMed ID: 25982283)
1. IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.
Samanta S; Sun H; Goel HL; Pursell B; Chang C; Khan A; Greiner DL; Cao S; Lim E; Shultz LD; Mercurio AM
Oncogene; 2016 Mar; 35(9):1111-21. PubMed ID: 25982283
[TBL] [Abstract][Full Text] [Related]
2. IMP3 promotes TNBC stem cell property through miRNA-34a regulation.
Huang QD; Zheng SR; Cai YJ; Chen DL; Shen YY; Lin CQ; Hu XQ; Wang XH; Shi H; Guo GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2688-2696. PubMed ID: 29771420
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
4. IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer.
Samanta S; Guru S; Elaimy AL; Amante JJ; Ou J; Yu J; Zhu LJ; Mercurio AM
Cell Rep; 2018 May; 23(9):2559-2567. PubMed ID: 29847788
[TBL] [Abstract][Full Text] [Related]
5. IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.
Su P; Hu J; Zhang H; Li W; Jia M; Zhang X; Wu X; Cheng H; Xiang L; Zhou G
Int J Clin Exp Pathol; 2014; 7(6):3008-17. PubMed ID: 25031719
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of IMP3 expression as a determinant of chemosensitivity in triple-negative breast cancer.
Ohashi R; Sangen M; Namimatsu S; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
Pathol Res Pract; 2017 Sep; 213(9):1160-1165. PubMed ID: 28756977
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer.
Sjekloča N; Tomić S; Mrklić I; Vukmirović F; Vučković L; Lovasić IB; Maras-Šimunić M
Medicine (Baltimore); 2020 Feb; 99(7):e19091. PubMed ID: 32049813
[TBL] [Abstract][Full Text] [Related]
8. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor.
Kim HY; Ha Thi HT; Hong S
Cancer Lett; 2018 Feb; 415():30-39. PubMed ID: 29217458
[TBL] [Abstract][Full Text] [Related]
9. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
10. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion.
Pasiliao CC; Chang CW; Sutherland BW; Valdez SM; Schaeffer D; Yapp DT; Ng SS
BMC Cancer; 2015 Apr; 15():266. PubMed ID: 25886367
[TBL] [Abstract][Full Text] [Related]
11. IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.
Samanta S; Pursell B; Mercurio AM
J Biol Chem; 2013 May; 288(18):12569-73. PubMed ID: 23539627
[TBL] [Abstract][Full Text] [Related]
12. Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
Samanta S; Sharma VM; Khan A; Mercurio AM
Oncogene; 2012 Nov; 31(44):4689-97. PubMed ID: 22266872
[TBL] [Abstract][Full Text] [Related]
13. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.
Storci G; Sansone P; Trere D; Tavolari S; Taffurelli M; Ceccarelli C; Guarnieri T; Paterini P; Pariali M; Montanaro L; Santini D; Chieco P; Bonafé M
J Pathol; 2008 Jan; 214(1):25-37. PubMed ID: 17973239
[TBL] [Abstract][Full Text] [Related]
14. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
16. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
17. HES1 promotes breast cancer stem cells by elevating Slug in triple-negative breast cancer.
Li X; Li Y; Du X; Wang X; Guan S; Cao Y; Jin F; Li F
Int J Biol Sci; 2021; 17(1):247-258. PubMed ID: 33390847
[TBL] [Abstract][Full Text] [Related]
18. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
Chen YL; Jeng YM; Hsu HC; Lai HS; Lee PH; Lai PL; Yuan RH
Int J Surg; 2013; 11(1):85-91. PubMed ID: 23246869
[TBL] [Abstract][Full Text] [Related]
20. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
